SARA RAY: Open Payments
NPI 1750846986 · ROSEBURG, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$197 in 8 payments from 6 companies in 2025. Trend: 2023 $613 · 2024 $211 · 2025 $197
Food & beverage: $197
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $63 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| GENZYME CORPORATION | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $23 |
| EMD Serono, Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: CALQUENCE, BLENREP, SARCLISA, JEMPERLI, RYBREVANT, OPDIVO.
Industry payments across OR — which companies pay providers there.
